One practice's experiment in refusing detail rep visits

Journal of Family Practice

Volumn 60, Issue 8, 2011, Pages

  Evans, David V ^a   Hartung, Daniel M ^b   Andeen, Gabriel ^c   Mahler, Jo ^c   Haxby, Dean G ^b   Kraemer, Dale F ^b   Fagnan, Lyle J ^c  

^a Madras Medical Group   (United States)

^b OREGON STATE UNIVERSITY   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DRUG INDUSTRY; GENERAL PRACTICE; HEALTH CARE POLICY; HUMAN; MEDICAL PERSONNEL; MEDICAL STAFF; NURSE; PHARMACEUTICAL CARE; PROFESSIONAL PRACTICE; SEMI STRUCTURED INTERVIEW; AMBULATORY CARE; CLINICAL PRACTICE; CONFLICT OF INTEREST; MEDICAL ETHICS; PUBLIC RELATIONS; QUESTIONNAIRE; UNITED STATES;

DRUG;

CONFLICT OF INTEREST; DRUG INDUSTRY; ETHICS, MEDICAL; FAMILY PRACTICE; HUMANS; INTERPROFESSIONAL RELATIONS; OFFICE VISITS; OREGON; PHARMACEUTICAL PREPARATIONS; PHYSICIAN'S PRACTICE PATTERNS; QUESTIONNAIRES;

EID: 80053635041     PISSN: 00943509     EISSN: 15337294     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Campbell EG, Gruen RL, Mountford J, et al. A national survey of physician-industry relationships. N Engl J Med. 2007;356:1742-1750. (Pubitemid 46658706)
2. Wazana A. Physicians and the pharmaceutical industry: is a gift ever just a gift? JAMA. 2000;283:373-380. (Pubitemid 30051756)
3. Chew LD, O'Young TS, Hazlet TK, et al. A physician survey of the effect of drug sample availability on physicians' behavior. J Gen Intern Med. 2000;15:478-483. (Pubitemid 30640259)
4. Symm B, Averitt M, Forjuoh SN, et al. Effects of using free sample medications on the prescribing practices of family physicians. J Am Board Fam Med. 2006;19:443-449. (Pubitemid 44577202)
5. Cutrona SL, Woolhandler S, Lasser KE, et al. Characteristics of recipients of free prescription drug samples: a nationally representative analysis. Am J Public Health. 2008;98:284-2896.
6. Dill JL, Generali JA. Medication sample labeling practices. Am J Health Syst Pharm. 2000;57:2087-2090.
7. Backer EL, Lebsack JA, Van Tonder RJ, et al. The value of pharmaceutical representative visits and medication samples in community-based family practices. J Fam Pract. 2000;49:811-816.
8. Hayes TM, Allery LA, Harding KG, et al. Continuing education for general practice and the role of the pharmaceutical industry. Br J Gen Pract. 1990;40:510-512.
9. McKinney WP, Schiedermayer DL, Lurie N, et al. Attitudes of internal medicine faculty and residents toward professional interaction with pharmaceutical sales representatives. JAMA. 1990;264:1693-1697. (Pubitemid 20324351)
10. National Physicians Alliance. Available at: http://npalliance.org/wp- content/uploads/IssueBrief-Integrity-HighRes.pdf. Accessed July 14, 2011.
11. No Free Lunch. About us. Available at: http://www.nofreelunch.org. Accessed July 14, 2011.
12. American Medical Student Association. PharmFree. Best practice policies. Available at: http://www.pharmfree.org/campaign. Accessed July 14, 2011.
13. Blake RL, Jr., Early EK. Patients' attitudes about gifts to physicians from pharmaceutical companies. J Am Board Fam Pract. 1995;8:457-464.
14. Brett AS, Burr W, Moloo J. Are gifts from pharmaceutical companies ethically problematic? A survey of physicians. Arch Intern Med. 2003;163:2213-2218. (Pubitemid 37248786)
15. Brody H. The company we keep: why physicians should refuse to see pharmaceutical representatives. Ann Fam Med. 2005;3:82-85. (Pubitemid 40203953)
16. Choudhry NK, Stelfox HT, Detsky AS. Relationships between authors of clinical practice guidelines and the pharmaceutical industry. JAMA. 2002;287:612-617. (Pubitemid 34252013)
17. Eaton L. Readers want transparency in link between doctors and drug firms. BMJ. 2003;326:1352.
18. Blumenthal D. Doctors and drug companies. N Engl J Med. 2004;351:1885-1890. (Pubitemid 39426325)
19. Stelfox HT, Chua G, O'Rourke K, et al. Conflict of interest in the debate over calcium-channel antagonists. N Engl J Med. 1998;338:101-106. (Pubitemid 28042274)
20. Studdert DM, Mello MM, Brennan TA. Financial conflicts of interest in physicians' relationships with the pharmaceutical industry - self-regulation in the shadow of federal prosecution. N Engl J Med. 2004;351:1891-1900. (Pubitemid 39426326)
21. Saul S. Gimme an Rx! Cheerleaders pep up drug sales. The New York Times. November 28, 2005. Available at: http://www.nytimes.com/2005/11/28/business/ 28cheer.html. Accessed July 17, 2010.
22. Saul S. Drug makers pay for lunch as they pitch. The New York Times. July 28, 2006. Available at: http://www.nytimes.com/2006/07/28/business/28lunch. html. Accessed July 17, 2010.
23. Saul S. Doctors object to gathering of drug data. The New York Times. May 4, 2006. Available at: http://www.nytimes.com/2006/05/04/business/04prescribe. html. Accessed July 17, 2010.
24. Zuger A. fever pitch: getting doctors to prescribe is big business. The New York Times. January 11, 1999. Available at: http://www.nytimes.com/1999/01/ 11/us/fever-pitch-getting-doctors-to-prescribe-is-big-business.html. Accessed July 17, 2010.
25. Brennan TA, Rothman DJ, Blank L et al. Health industry practices that create conflicts of interest: a policy proposal for academic medical centers. JAMA. 2006;295:429-433. (Pubitemid 43144979)
26. Association of American Medical Colleges. Industry Funding of Medical Education: Report of a AAMC Task Force. Washington, DC: AAMC; 2008.
27. Campbell EG, Regan S, Gruen RL et al. Professionalism in medicine: results of a national survey of physicians. Ann Intern Med. 2007;147:795-802. (Pubitemid 351664442)
28. Westfall JM, McCabe J, Nicholas RA. Personal use of drug samples by physicians and office staff. JAMA. 1997;278:141-143. (Pubitemid 27287672)
29. Dana J, Loewenstein G. A social science perspective on gifts to physicians from industry. JAMA. 2003;290:252-255. (Pubitemid 37430065)
30. Meier B, Saul S. Marketing of Vioxx: how Merck played game of catch-up. The New York Times. February 11, 2005. Available at: http://www.nytimes.com/ 2005/02/11/business/11merck.html. Accessed July 17, 2010.
31. Seitz K. Do patients believe physicians are influenced by all those "Drug Pens". Presented at 36th Annual Meeting of the North America Primary Care Research Group. November 15-18, 2008; Puerto Rico.